EASTON BIOPHARMACEUTICALS(688513.SH)

Last Updated 00:00:00
longbridge loading

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Wallstreetcn·
SH
688336
-2.61%
SH
688513
-2.11%
HK
01877
+0.80%
Wallstreetcn·
SH
688336
-2.61%
SH
688513
-2.11%
HK
01877
+0.80%

EASTON BIOPHARMACEUTICALS: The company's hydrochloride deoxycorticosterone injection and beraprost sodium tablets are expected to be selected for national centralized drug procurement

Zhitong·
SH
688513
-2.11%
Zhitong·
SH
688513
-2.11%

EASTON BIOPHARMACEUTICALS released its performance for the first three quarters, with a net profit attributable to the parent company of 220 million yuan, a year-on-year increase of 1.45%

Zhitong·
SH
688513
-2.11%
Zhitong·
SH
688513
-2.11%

EASTON BIOPHARMACEUTICALS: Ailamod Tablets have obtained a drug registration certificate

Zhitong·
SH
688513
-2.11%
Zhitong·
SH
688513
-2.11%

SDKX and EASTON BIOPHARMACEUTICALS jointly expand the overseas market for Apalutamide tablets

Zhitong·
SH
688513
-2.11%
SH
688136
-6.63%
Zhitong·
SH
688513
-2.11%
SH
688136
-6.63%

EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificate

Zhitong·
SH
688513
-2.11%
Zhitong·
SH
688513
-2.11%

The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%

Zhitong·
SZ
300204
-1.12%
SH
600276
-1.96%
SH
688513
-2.11%
Zhitong·
SZ
300204
-1.12%
SH
600276
-1.96%
SH
688513
-2.11%

Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines

Zhitong·
SH
688166
-1.44%
SZ
301096
-2.38%
SH
688658
-5.35%
Zhitong·
SH
688166
-1.44%
SZ
301096
-2.38%
SH
688658
-5.35%

EASTON BIOPHARMACEUTICALS: Hydrochloride Arolol Tablets have obtained a drug registration certificate

Zhitong·
SH
688513
-2.11%
Zhitong·
SH
688513
-2.11%

Innovative drug concept stocks show partial strength, Thalys hits the limit up

Zhitong·
SH
603127
+0.60%
HK
06127
+2.37%
SZ
300436
+1.17%
Zhitong·
SH
603127
+0.60%
HK
06127
+2.37%
SZ
300436
+1.17%
© 2026 Longbridge｜Disclaimer